Magdalena Zgliczyńska
Magdalena Zgliczyńska has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Michał Ciebiera
Warsaw Institute of Women’s Health, 00-189 Warsaw, Poland
2 shared publications - Tomasz Łoziński
Department of Obstetrics and Gynecology, Pro-Familia Hospital, Rzeszow, Poland
2 shared publications Aneta Balabas
Department of Genetics, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
1 shared publication- Ayman Al-Hendy
Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA
1 shared publication Dominika Krawczyk
Department of Obstetrics, Perinatology and Neonatology, Centre of Postgraduate Medical Education, Warsaw, Poland
1 shared publicationDorota Leszczyńska
Department of Endocrinology, Centre of Postgraduate Medical Education, Cegłowska, Warsaw, Poland
1 shared publication
Latest Publications
- Open Access
- 29 August 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1655581
Analysis of the microbiota of pregnant women in relation to weight gain during pregnancy – a pilot study
Introduction: Excessive body weight was associated with changes in individual microbiota. However, limited research on the impact of excessive gestational weight gain (GWG) revealed that microbiota patterns related to GWG differed from those linked to pregestational overweight or obesity.Aim: The aim was to compare differences in the microbiota of women in the third trimester of gestation who had excessive and non-excessive weight gain during pregnancy.Material and methods: Women with a singleton gestation at 34 + 0 weeks and normal pregestational body mass index were recruited to the study. Patients who were diagnosed with excessive weight gain formed the study group (n=11), while those with non-excessive weight gain formed the control group (n=10).Results: In cervico-vaginal samples, bacterial 16S rRNA gene sequencing demonstrated a decrease in alpha diversity, measured with the Shannon index, in the study group compared to the control group. While the difference was not statistically significant after correction for multiple testing, the Chao index showed a persistent trend toward reduced species richness in the study group. In stool samples, we identified 29 genera with differential representation between the groups, including nine overrepresented and ten underrepresented genera. The cervico-vaginal microbiota analysis detected 12 species distinguishing the study group from the controls, with four genera (Ralstonia, Pandoraea, Kocuria, and Rhodobacteraceae unclassified) being more prevalent in the study group. However, in both sites none difference was found to be statistically significant after p-value correction.Conclusions: Despite small sample size, we demonstrated slight trends in microbiota composition between groups. These suggest potential differences in microbial diversity and composition associated with excessive GWG, which supports further investigation.
- 29 August 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1655581
Open AccessAnalysis of the microbiota of pregnant women in relation to weight gain during pregnancy – a pilot study
Introduction: Excessive body weight was associated with changes in individual microbiota. However, limited research on the impact of excessive gestational weight gain (GWG) revealed that microbiota patterns related to GWG differed from those linked to pregestational overweight or obesity.Aim: The aim was to compare differences in the microbiota of women in the third trimester of gestation who had excessive and non-excessive weight gain during pregnancy.Material and methods: Women with a singleton gestation at 34 + 0 weeks and normal pregestational body mass index were recruited to the study. Patients who were diagnosed with excessive weight gain formed the study group (n=11), while those with non-excessive weight gain formed the control group (n=10).Results: In cervico-vaginal samples, bacterial 16S rRNA gene sequencing demonstrated a decrease in alpha diversity, measured with the Shannon index, in the study group compared to the control group. While the difference was not statistically significant after correction for multiple testing, the Chao index showed a persistent trend toward reduced species richness in the study group. In stool samples, we identified 29 genera with differential representation between the groups, including nine overrepresented and ten underrepresented genera. The cervico-vaginal microbiota analysis detected 12 species distinguishing the study group from the controls, with four genera (Ralstonia, Pandoraea, Kocuria, and Rhodobacteraceae unclassified) being more prevalent in the study group. However, in both sites none difference was found to be statistically significant after p-value correction.Conclusions: Despite small sample size, we demonstrated slight trends in microbiota composition between groups. These suggest potential differences in microbial diversity and composition associated with excessive GWG, which supports further investigation.
- Open Access
- 24 August 2023
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 24 (16) , 1799-1809
GnRH agonists and antagonists in therapy of symptomatic uterine fibroids – current roles and future perspectives
Uterine fibroids are the most common noncancerous tumors in women of childbearing age. This review was developed to evaluate the current role of gonadotropin-releasing hormone (GnRH) agonists and antagonists in therapy of symptomatic uterine fibroids. There is a great need of alternative methods to surgical treatment of uterine fibroids. The hormonal therapy remains the first line treatment option for most patients. GnRH analogs (agonists and antagonists) modulate the pulsatile release of GnRH. This review summarizes the available literature concerning pharmacologic principles underlying the mechanism of action of GnRH and its analogs, as well as individual therapeutic applications to which these drugs have been applied. In many cases it is possible to try to treat uterine fibroids pharmacologically. Both groups of GnRH analogs are used in therapy, agonists instead as a preparation for surgery, and antagonists as a drug for long-term use. It is essential to develop this path further and look for at least long-term release systems or new methods of administering these drugs. It is also important from the patient's perspective to search for possible drugs that may give an additive effect of decreasing side effects when combined with GnRH analogs.
- 24 August 2023
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 24 (16) , 1799-1809
Open AccessGnRH agonists and antagonists in therapy of symptomatic uterine fibroids – current roles and future perspectives
Uterine fibroids are the most common noncancerous tumors in women of childbearing age. This review was developed to evaluate the current role of gonadotropin-releasing hormone (GnRH) agonists and antagonists in therapy of symptomatic uterine fibroids. There is a great need of alternative methods to surgical treatment of uterine fibroids. The hormonal therapy remains the first line treatment option for most patients. GnRH analogs (agonists and antagonists) modulate the pulsatile release of GnRH. This review summarizes the available literature concerning pharmacologic principles underlying the mechanism of action of GnRH and its analogs, as well as individual therapeutic applications to which these drugs have been applied. In many cases it is possible to try to treat uterine fibroids pharmacologically. Both groups of GnRH analogs are used in therapy, agonists instead as a preparation for surgery, and antagonists as a drug for long-term use. It is essential to develop this path further and look for at least long-term release systems or new methods of administering these drugs. It is also important from the patient's perspective to search for possible drugs that may give an additive effect of decreasing side effects when combined with GnRH analogs.
- Open Access
- 23 August 2023
- Published by Bioscientifica in Endocrine Connections
- Vol. 12 (11)
Determination of vitamin D status in singleton and twin gestations using CLIA and LC-MS/MS
Objective: Vitamin D plays an important role during pregnancy. The aim was to compare vitamin D status in a group of singleton (SP) and twin pregnancies (TP) using two diagnostic methods: chemiluminescence immunoassay (CLIA) and liquid chromatography with tandem mass spectrometry (LC-MS/MS). Design: This is a cross-sectional study. Methods: The study was conducted in the population of SP and TP at the gestational age above 20 + 0 at the Bielanski Hospital in Warsaw, Poland, between October 2020 and January 2023. All patients had their venous blood samples collected and were given an original survey containing questions on demography and vitamin D supplementation. Results: The study group included 53 Caucasian women with SP and 78 with TP aged from 21 to 47. Considering LC-MS/MS, patients with TP had lower concentrations of 25-hydroxyvitamin D (25(OH)D) than patients with SP. However, no significant difference was observed in the frequency of the occurrence of vitamin D deficiency (25(OH)D < 30 ng/mL). In both groups, the levels obtained with CLIA were significantly lower than in case of LC-MS/MS, however, strongly correlated. The intermethod agreement accounted for 52.4% and the Cohen’s kappa coefficient was 0.142. Conclusions: The concentration of 25(OH)D in pregnant women depends on the type of gestation (SP/TP) and on the diagnostic methods used (CLIA/LC-MS/MS). Based on LC-MS/MS, the incidence of vitamin D deficiency was low in our group and no differences occurred in its frequency between SP and TP. The intermethod agreement between CLIA and LC-MS/MS on the detection of vitamin D deficiency was low. Significance statement: This is the first study to compare the concentration of 25(OH)D levels between SP and TP using two methods: CLIA and the gold standard – LC-MS/MS. Based on LC-MS/MS, a low incidence of vitamin D deficiency was observed in our group, in which the vast majority of patients took cholecalciferol supplements. Moreover, there were no differences in its frequency between SP and TP. However, the 25(OH)D level was significantly lower in TP. The intermethod agreement between CLIA and LC-MS/MS on the detection of vitamin D deficiency was low, which is associated with substantial clinical implications.
- 23 August 2023
- Published by Bioscientifica in Endocrine Connections
- Vol. 12 (11)
Open AccessDetermination of vitamin D status in singleton and twin gestations using CLIA and LC-MS/MS
Objective: Vitamin D plays an important role during pregnancy. The aim was to compare vitamin D status in a group of singleton (SP) and twin pregnancies (TP) using two diagnostic methods: chemiluminescence immunoassay (CLIA) and liquid chromatography with tandem mass spectrometry (LC-MS/MS). Design: This is a cross-sectional study. Methods: The study was conducted in the population of SP and TP at the gestational age above 20 + 0 at the Bielanski Hospital in Warsaw, Poland, between October 2020 and January 2023. All patients had their venous blood samples collected and were given an original survey containing questions on demography and vitamin D supplementation. Results: The study group included 53 Caucasian women with SP and 78 with TP aged from 21 to 47. Considering LC-MS/MS, patients with TP had lower concentrations of 25-hydroxyvitamin D (25(OH)D) than patients with SP. However, no significant difference was observed in the frequency of the occurrence of vitamin D deficiency (25(OH)D < 30 ng/mL). In both groups, the levels obtained with CLIA were significantly lower than in case of LC-MS/MS, however, strongly correlated. The intermethod agreement accounted for 52.4% and the Cohen’s kappa coefficient was 0.142. Conclusions: The concentration of 25(OH)D in pregnant women depends on the type of gestation (SP/TP) and on the diagnostic methods used (CLIA/LC-MS/MS). Based on LC-MS/MS, the incidence of vitamin D deficiency was low in our group and no differences occurred in its frequency between SP and TP. The intermethod agreement between CLIA and LC-MS/MS on the detection of vitamin D deficiency was low. Significance statement: This is the first study to compare the concentration of 25(OH)D levels between SP and TP using two methods: CLIA and the gold standard – LC-MS/MS. Based on LC-MS/MS, a low incidence of vitamin D deficiency was observed in our group, in which the vast majority of patients took cholecalciferol supplements. Moreover, there were no differences in its frequency between SP and TP. However, the 25(OH)D level was significantly lower in TP. The intermethod agreement between CLIA and LC-MS/MS on the detection of vitamin D deficiency was low, which is associated with substantial clinical implications.
- Open Access
- 12 February 2023
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 40 (1) , 2174274
Adverse events and complications after magnetic resonance-guided focused ultrasound (MRgFUS) therapy in uterine fibroids – a systematic review and future perspectives
The aim of this review was to analyze and summarize the most common adverse events (AEs) and complications after magnetic resonance-guided focused ultrasound (MRgFUS) therapy in uterine fibroids (U...
- 12 February 2023
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 40 (1) , 2174274
Open AccessAdverse events and complications after magnetic resonance-guided focused ultrasound (MRgFUS) therapy in uterine fibroids – a systematic review and future perspectives
The aim of this review was to analyze and summarize the most common adverse events (AEs) and complications after magnetic resonance-guided focused ultrasound (MRgFUS) therapy in uterine fibroids (U...
- Open Access
Micronutrients in Multiple Pregnancies—The Knowns and Unknowns: A Systematic Review
Maternal diet and nutritional status are of key importance with regard to the short- and long-term health outcomes of both the mother and the fetus. Multiple pregnancies are a special phenomenon in the context of nutrition. The presence of more than one fetus may lead to increased metabolic requirements and a faster depletion of maternal macro- and micro- nutrient reserves than in a singleton pregnancy. The aim of this systematic review was to gather available knowledge on the supply and needs of mothers with multiple pregnancies in terms of micronutrients and the epidemiology of deficiencies in that population. It was constructed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement (PRISMA). The authors conducted a systematic literature search with the use of three databases: PubMed/MEDLINE, Scopus and Embase. The last search was run on the 18 October 2020 and identified 1379 articles. Finally, 12 articles and 1 series of publications met the inclusion criteria. Based on the retrieved studies, it may be concluded that women with multiple pregnancies might be at risk of vitamin D and iron deficiencies. With regard to other microelements, the evidence is either inconsistent, scarce or absent. Further in-depth prospective and population studies are necessary to determine if nutritional recommendations addressed to pregnant women require adjustments in cases of multiple gestations.
Open AccessMicronutrients in Multiple Pregnancies—The Knowns and Unknowns: A Systematic Review
Maternal diet and nutritional status are of key importance with regard to the short- and long-term health outcomes of both the mother and the fetus. Multiple pregnancies are a special phenomenon in the context of nutrition. The presence of more than one fetus may lead to increased metabolic requirements and a faster depletion of maternal macro- and micro- nutrient reserves than in a singleton pregnancy. The aim of this systematic review was to gather available knowledge on the supply and needs of mothers with multiple pregnancies in terms of micronutrients and the epidemiology of deficiencies in that population. It was constructed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement (PRISMA). The authors conducted a systematic literature search with the use of three databases: PubMed/MEDLINE, Scopus and Embase. The last search was run on the 18 October 2020 and identified 1379 articles. Finally, 12 articles and 1 series of publications met the inclusion criteria. Based on the retrieved studies, it may be concluded that women with multiple pregnancies might be at risk of vitamin D and iron deficiencies. With regard to other microelements, the evidence is either inconsistent, scarce or absent. Further in-depth prospective and population studies are necessary to determine if nutritional recommendations addressed to pregnant women require adjustments in cases of multiple gestations.